Grant of Option Clause Example with 21 Variations from Business Contracts

This page contains Grant of Option clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, a Delaware corporation (the "Company"), on , 20[ ] (the "Grant Date") to [ ], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 par value per share, of the Company ("Common Stock") at $[ ] per Share. Unless earlier terminated, this optio...n shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in ALNYLAM PHARMACEUTICALS, INC. contract

Variations of a "Grant of Option" Clause from Business Contracts

Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Ophthotech Corporation, a Delaware corporation (the "Company"), on , 20[ ] August 31, 2015 (the "Grant Date") to [ ], Hemic Bjarke, an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock Incentive Plan (the "Plan"), herein, a total of [ ] 120,000 shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the Comp...any ("Common Stock") at $[ ] $44.03 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, Time, on [ ] August 30, 2025 (the "Final Exercise Date"). The option evidenced by this agreement was granted to the Participant pursuant to the inducement grant exception under NASDAQ Stock Market Rule 5635(c)(4), and not pursuant to the Company's 2013 Stock Incentive Plan (the "Plan") or any equity incentive plan of the Company, as an inducement that is material to the Participant's employment with the Company. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in Ophthotech Corp. contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, PTC Therapeutics, Inc., a Delaware corporation (the "Company"), on , 20[ ] [·] (the "Grant Date") to [ ], [·], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock Incentive Plan (the "Plan"), herein, a total of [ ] [·] shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the Company ("Common Stock") at $...[ ] $[·] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] [·] (the "Final Exercise Date"). The option evidenced by this agreement was granted to the Participant pursuant to the inducement grant exception under NASDAQ Stock Market Rule 5635(c)(4), and not pursuant to the Company's 2013 Long Term Incentive Plan (the "Plan") or any equity incentive plan of the Company, as an inducement that is material to the Participant's employment with the Company. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in PTC THERAPEUTICS, INC. contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, PTC Therapeutics, Inc., a Delaware corporation (the "Company"), on , 20[ ] [·] (the "Grant Date") to [ ], an employee [·], a [employee]/[director]/[consultant] of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock 2013 Long-Term Incentive Plan (the "Plan"), a total of [ ] [·] shares (the "Shares") of common stock, $.01 $0.001 par value per... share, of the Company ("Common Stock") at $[ ] $[·] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] January 1, 2025 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in PTC THERAPEUTICS, INC. contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, PTC Therapeutics, Inc., a Delaware corporation (the "Company"), on , 20[ ] [·] (the "Grant Date") to [ ], [·], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock 2013 Long-Term Incentive Plan (the "Plan"), a total of [ ] [·] shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the Company ("Common Stock...") at $[ ] $[·] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] [·] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). "Code") to the maximum extent permitted by applicable federal tax laws. Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in PTC THERAPEUTICS, INC. contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Pacira BioSciences, Inc., a Delaware corporation (the "Company"), on , 20[ ] [GRANT DATE] (the "Grant Date") to [ ], an employee of the Company [PARTICIPANT NAME], (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Amended and Restated 2011 Stock Incentive Plan (the "Plan"), a total of [ ] [NUMBER OF AWARDS GRANTED] shares (the "Shares") of common stock, $....01 $0.001 par value per share, of the Company ("Common Stock") at $[ ] $[GRANT PRICE] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern Pacific time, on [ ] [EXPIRATION DATE] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in Pacira Pharmaceuticals, Inc. contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Argos Therapeutics, Inc., a Delaware corporation (the "Company"), on , 20[ ] [ ], 20[__] (the "Grant Date") to [ ], an employee [an][a] [employee], [consultant], [director] of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2014 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.001 par value per ...share, of the Company ("Common Stock") at an exercise price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] ], 20[__] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in ARGOS THERAPEUTICS INC contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, Inc., a Delaware corporation (the "Company"), on , 20[ ] (the "Grant Date") to [ ], an employee [employee], [consultant], [director] of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Stock Incentive Plan (the "Plan"), herein, a total of [ ] shares (the "Shares") of common stock, $.01 $00.01 par value per share, of the Company ("Common Stock"...) at $[ ] per Share. This option has been granted pursuant to an exception under Rule 5635(c)(4) of the NASDAQ Stock Market Rules, is not issued under the Company's Amended and Restated 2009 Stock Incentive Plan (the "Plan") and does not reduce the share reserve under the Plan. However, for purposes of interpreting the applicable provisions of this option, the terms and conditions of the Plan (other than those applicable to the share reserve) shall govern and apply to this option as if such option had actually been issued under the Plan. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in ALNYLAM PHARMACEUTICALS, INC. contract
Grant of Option. This agreement evidences the grant by Alnylam Spring Bank Pharmaceuticals, Inc,, Inc., a Delaware corporation (the "Company"), on , 20[ ] March 26, 2015 (the "Grant Date") to [ ], an employee employee, consultant or director of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2014 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.0001 par value per share, of the Co...mpany ("Common Stock") at $[ ] $2.32 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] March 25, 2015 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in Spring Bank Pharmaceuticals, Inc. contract
Grant of Option. This agreement evidences the grant by Alnylam Pharmaceuticals, Inc,, a Delaware corporation (the "Company"), on , 20[ ] [OPTION DATE,'Month DD, YYYY'] (the "Grant Date") to [ ], [FIRST NAME, LAST NAME], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 Amended and Restated 2004 Stock Incentive Plan (the "Plan"), a total of [ ] [TOTAL SHARES GRANTED] shares (the "Shares") of common stock, $.01 par ...value per share, of the Company ("Common Stock") at $[ ] [OPTION PRICE] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ] [EXPIRE DATE PERIOD] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in ALNYLAM PHARMACEUTICALS, INC. contract
Grant of Option. This agreement Incentive Stock Option Agreement (the "Agreement") evidences the grant by Alnylam Pharmaceuticals, Inc,, IMARA Inc., a Delaware corporation (the "Company"), on [ , 20[ 20 ] (the "Grant Date") to [ ], an employee of the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company's 2009 2016 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $.01 $0.001 par value per share, of the C...ompany ("Common Stock") at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement Agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. View More
Found in IMARA Inc. contract